Home - National Multiple Sclerosis Society

Skip to navigation Skip to content
National MS Society
Email not displaying correctly? View it in your browser.
August 2013 MS eNEWS
Estriol may offer protection

Sex hormone will be evaluated in 12-month study

MS relapses are decreased by 80% during late pregnancy, which may be due to estriol, the major estrogen of pregnancy. Dr. Rhonda Voskuhl, UCLA, and investigators in California, Colorado, New Mexico, and Pennsylvania seek women with MS for a multi-center clinical trial that will explore estriol’s effects on MS-related cognitive issues. In an earlier, Society-funded study, Dr. Voskuhl’s team showed that estriol decreased MS activity in 12 women living with the disease.

Read more about this study

Check in with Dr. Voskuhl on other gender-based research

Explore MS clinical trials currently recruiting

Join the conversation about MS cognitive issues at MSconnection.org

 MSconnection.org 

facebook twitter youtube flickr linkedin

 


YOUR GIFT

Ensure that no opportunity is wasted

Ensure that no opportunity is wasted to help end MS forever

T-cell therapy T-cell therapy studied in
secondary-progressive MS

Researchers in the U.S. and Canada are recruiting 180 people with secondary-progressive MS for a phase II clinical trial of Tcelna, a personalized T-cell therapy using a person’s own immune cells. The therapy is tailored to each person’s immune response to myelin and has previously been shown to reduce MS-related T-cell activity.

Read more about this novel approach

 

Bike MSDon’t just ride, Bike MS

It’s not the miles that matter – it’s the unforgettable journey and the knowledge that you’re changing lives, making every mile that much sweeter. Go the distance for a world free of MS – choose from 100 extraordinary cycling events across the country. Register now for Bike MS.

Find your ride

 

More MS News

Aug 7: New physician training program to improve MS care

Aug 5: Current and completed pregnancy registries for MS therapies

Read more about these and other recent reports

This communication is partially sponsored through the generous support of
Biogen Idec; Genzyme, a Sanofi company; Novartis Pharmaceuticals Corporation; and Teva Neuroscience, Inc.
MS Active Source Genzyme, a Sanofi company Novartis Teva Neuroscience, Inc.
Join a Walk MS Event       Join a Bike MS Event      Shop at the Society Store

National MS Society | View as Web page | Subscribe | Legal Notice/Privacy Policy | Email Preferences | Unsubscribe

MS stops people from moving. The National MS Society exists to make sure it doesn’t. We are a collective of passionate individuals, moving together to create a world free of MS.
JOIN THE MOVEMENT®

Please do not reply to this email as we are unable to quickly respond to messages sent to this address. To receive information about living with MS, Bike MS or Walk MS — or to contact National MS Society staff in your area — please
visit our website.

Early and ongoing treatment with an FDA-approved therapy can make a difference for people with multiple sclerosis. Learn about your options by talking to your health care professional and contacting the National MS Society at http://www.nationalmssociety.org/ or 1-800-344-4867.

National Multiple Sclerosis Society | 733 Third Avenue | New York, NY | 10017

This message was sent to   .
To ensure that you continue to receive our emails, please add us to your address book.